TRPC6 counteracts TRPC3-Nox2 protein complex leading to attenuation of hyperglycemia-induced heart failure in mice

Sayaka Oda1,2, Takuro Numaga-Tomita1,2, Naoyuki Kitajima1,3

  • 1Division of Cardiocirculatory Signaling, National Institute for Physiological Sciences (Okazaki Institute for Integrative Bioscience), National Institutes of Natural Sciences, Aichi, 444-8787, Japan.

Scientific Reports
|August 10, 2017
PubMed

Insights

Transient Receptor Potential Canonical 3 (TRPC3) channels protect against heart failure. TRPC3 disruption by TRPC6 loss attenuates hyperglycemia-induced heart failure by destabilizing NADPH oxidase 2 (Nox2) complexes.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Oxidative Stress Research

Background:

  • Hyperglycemia-induced reactive oxygen species (ROS) are a major heart failure risk factor.
  • Transient Receptor Potential Canonical 3 (TRPC3) channels, complexed with NADPH oxidase 2 (Nox2), mediate pressure overload-induced cardiac fibrosis.
  • The role of TRPC6 in cardiac function and heart failure remains largely unknown.

Purpose of the Study:

  • To investigate the role of TRPC6 in pressure overload-induced heart failure.
  • To elucidate the mechanism by which TRPC6 influences cardiac function, particularly in the context of hyperglycemia and oxidative stress.
  • To determine the relationship between TRPC3, TRPC6, and Nox2 in cardiac pathophysiology.

Main Methods:

  • Utilized TRPC6-deficient mice subjected to transverse aortic constriction (TAC) to model pressure overload.
  • Administered streptozotocin to TRPC6-deficient mice to induce hyperglycemia and assess cardiac function.
  • Performed gene expression analysis, ROS production assays, and cytokine profiling in cardiac tissues.
  • Investigated protein-protein interactions between TRPC6, TRPC3, and Nox2 using molecular biology techniques.
  • Examined cytokine expression in rat cardiomyocytes following TRPC6 knockdown.

Main Results:

  • TRPC6 deficiency did not affect pressure overload-induced heart failure but reduced interstitial fibrosis.
  • TRPC6-deficient hearts showed increased inflammatory cytokine induction post-TAC.
  • Hyperglycemia exacerbated cardiac dysfunction and lipid peroxidation in TRPC6-deficient mice compared to wild-type and TRPC3-deficient mice.
  • TRPC6 knockdown increased basal cytokine expression in cardiomyocytes.
  • TRPC6 interacts with Nox2, but its abundance is inversely correlated with Nox2 levels.

Conclusions:

  • TRPC6 plays a complex role in cardiac response to stress, distinct from its interaction with TRPC3.
  • TRPC6 deficiency exacerbates hyperglycemia-induced cardiac dysfunction, potentially via altered inflammatory responses and lipid peroxidation.
  • TRPC6 appears to destabilize the TRPC3-Nox2 complex, suggesting a mechanism for attenuating hyperglycemia-induced heart failure.

Related Concept Videos